Signaling Pathways of BAFF and APRIL in B-Cell Development: Relevance to ANCA-Associated Vasculitis Pathogenesis
Background
ANCA-associated vasculitis (AAV) is a systemic autoimmune disorder characterized by necrotizing vasculitis affecting small- to medium-sized vessels. The role of autoreactive B cells in AAV pathogenesis is significant, as they produce ANCA and contribute to inflammatory processes. Understanding the mechanisms of B-cell activation and survival is essential.
Data Highlights
No numerical data provided in the source material.
Key Findings
BAFF and APRIL signaling pathways are upregulated in autoreactive B cells, contributing to AAV pathogenesis.
Elevated levels of soluble BAFF and APRIL persist in patients even after clinical remission, leading to relapse.
Active AAV is characterized by expansions of specific B-cell phenotypes, including plasmablasts and plasma cells.
Decreased BAFF receptor expression on memory B cells and increased TACI expression on transitional B cells are observed during AAV.
B-cell depletion therapy with rituximab is effective but requires repeated administration to maintain remission.
Targeting BAFF/APRIL signaling pathways may provide novel therapeutic strategies for AAV.
Clinical Implications
Persistent elevation of BAFF and APRIL in AAV patients may contribute to relapse after treatment. Understanding B-cell populations and their signaling pathways is important.
Conclusion
The dysregulation of BAFF and APRIL signaling in B cells is a critical factor in the pathogenesis of AAV.
